MX9701771A - Procedimiento para estabilizar acidos grasos poli-insturados y su aplicacion en terapia y cosmeticos. - Google Patents

Procedimiento para estabilizar acidos grasos poli-insturados y su aplicacion en terapia y cosmeticos.

Info

Publication number
MX9701771A
MX9701771A MX9701771A MX9701771A MX9701771A MX 9701771 A MX9701771 A MX 9701771A MX 9701771 A MX9701771 A MX 9701771A MX 9701771 A MX9701771 A MX 9701771A MX 9701771 A MX9701771 A MX 9701771A
Authority
MX
Mexico
Prior art keywords
fatty acids
cosmetics
therapy
application
polyunsaturated fatty
Prior art date
Application number
MX9701771A
Other languages
English (en)
Inventor
Jean-Robert Grinda
Original Assignee
Jean-Robert Grinda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jean-Robert Grinda filed Critical Jean-Robert Grinda
Publication of MX9701771A publication Critical patent/MX9701771A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C07C57/12—Straight chain carboxylic acids containing eighteen carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/50—Use of additives, e.g. for stabilisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)

Abstract

La invencion es concerniente con el campo de la química, en particular la química terapéutica y proporciona un método para la estabilizacion de los ácidos grasos no saturados o sus alquil ésteres inferiores. El método comprende las etapas de mezclar una solucion que comprende los ácidos o ésteres mencionados anteriormente en un disolvente inerte no hidroxilado, con una hidroxialquil celulosa y luego desolvatar tal preparacion con el fin de pulverizarla. Luego la preparacion se diluye o mezcla con un portador o excipiente inerte no toxico farmacéuticamente aceptable para preparar formulaciones farmacéuticas o con un diluyente o portador inrete para formulaciones cosméticas.
MX9701771A 1994-07-15 1997-03-07 Procedimiento para estabilizar acidos grasos poli-insturados y su aplicacion en terapia y cosmeticos. MX9701771A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9408810A FR2722410B1 (fr) 1994-07-15 1994-07-15 Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises entherapeutique

Publications (1)

Publication Number Publication Date
MX9701771A true MX9701771A (es) 1997-12-31

Family

ID=9465440

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9701771A MX9701771A (es) 1994-07-15 1997-03-07 Procedimiento para estabilizar acidos grasos poli-insturados y su aplicacion en terapia y cosmeticos.

Country Status (14)

Country Link
US (1) US5914347A (es)
EP (1) EP0796238B1 (es)
JP (1) JPH10508287A (es)
KR (1) KR100388818B1 (es)
AT (1) ATE193006T1 (es)
DE (1) DE69517050T2 (es)
DK (1) DK0796238T3 (es)
ES (1) ES2150004T3 (es)
FR (1) FR2722410B1 (es)
GR (1) GR3033990T3 (es)
MX (1) MX9701771A (es)
NZ (1) NZ289877A (es)
PT (1) PT796238E (es)
WO (1) WO1996002488A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741533B1 (fr) * 1995-11-28 1998-02-06 Grinda Jean Robert Procede de stabilisation des acides gras polyinsatures et utilisation de ces produits stabilises en cosmetologie
CA2627832C (en) * 1996-03-28 2012-12-11 Dsm Ip Assets B.V. Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
FR2802810A1 (fr) * 1999-12-23 2001-06-29 Grinda Jean Robert Nouveaux produits cosmetiques et therapeutiques a base de composes lipidiques et leur procede de preparation
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
DE112004001520B4 (de) * 2003-08-18 2008-04-10 Btg International Ltd. Verwendung eines Lipidglyzerids festgelegter Struktur zur Herstellung eines Medikamentes zur Behandlung der multiplen Sklerose
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
GB0504362D0 (en) 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
DK2493296T3 (en) * 2009-10-30 2019-04-15 Retrotope Inc REMOVAL OF OXIDATIVE STRESS STATES WITH PUFA DERIVATIVES
EP2708230A4 (en) * 2011-05-12 2014-12-03 Nippon Suisan Kaisha Ltd COMPOSITION FOR APPEARANCE ON THE SKIN FOR INFLAMMATORY DISEASES
AU2014358145C1 (en) 2013-12-04 2022-09-15 Nippon Suisan Kaisha, Ltd. Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil
WO2017091279A1 (en) 2015-11-23 2017-06-01 Retrotope, Inc. Site-specific isotopic labeling of 1, 4-diene systems
US11779910B2 (en) 2020-02-21 2023-10-10 Biojiva Llc Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2827452A (en) * 1955-05-31 1958-03-18 Univ Minnesota Stabilization of materials
US3450821A (en) * 1967-03-02 1969-06-17 Hoffmann La Roche Stable compositions containing eicosatetrayn - (5,8,11,14) - oic-(1) acid and derivatives thereof
JPS60258139A (ja) * 1984-06-05 1985-12-20 Nippon Oil & Fats Co Ltd 金属石けんの水分散体
FR2573653B1 (fr) * 1984-11-23 1988-02-26 Pf Medicament Compositions pharmaceutiques antiandrogenes a base d'acides gras
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid

Also Published As

Publication number Publication date
KR100388818B1 (ko) 2003-10-17
DE69517050D1 (de) 2000-06-21
PT796238E (pt) 2000-09-29
EP0796238A1 (fr) 1997-09-24
FR2722410A1 (fr) 1996-01-19
ES2150004T3 (es) 2000-11-16
GR3033990T3 (en) 2000-11-30
KR970706230A (ko) 1997-11-03
EP0796238B1 (fr) 2000-05-17
NZ289877A (en) 1998-05-27
DK0796238T3 (da) 2000-10-02
ATE193006T1 (de) 2000-06-15
JPH10508287A (ja) 1998-08-18
FR2722410B1 (fr) 1996-10-04
WO1996002488A1 (fr) 1996-02-01
US5914347A (en) 1999-06-22
DE69517050T2 (de) 2001-01-18

Similar Documents

Publication Publication Date Title
MX9701771A (es) Procedimiento para estabilizar acidos grasos poli-insturados y su aplicacion en terapia y cosmeticos.
YU66600A (sh) Farmaceutski preparati koji mogu da budu gelirani
MX9703556A (es) Composicion para bloquear los rayos solares y para curar heridas.
HUT64065A (en) Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient
EE03425B1 (et) Lihtsa koostise ja kõrge biosaadavusega tsüklosporiini preparaadid suu kaudu manustamiseks ja nende valmistamismeetod
HUT54999A (en) Process for producing imidazolyl-alkenic acids and pharmaceutical compositions containing them as active components
MY108074A (en) Preparation of polyhydroxy fatty acid amides in the presence of solvents
CS314490A2 (en) Stable, cosmetically acceptable topic gel-like preparation
EP0911021A3 (en) Methods and compositions for fine lines and/or wrinkles
HUT64013A (en) Process for producing hiv-inhibiting phenylacetamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient
AU4846690A (en) Polyunsaturated fatty acid derivatives, pharmaceutical compositions containing the same, method for the preparation thereof, and their use as medicament
SG46307A1 (en) New pyrazine derivatives the preparation and use thereof
AU2111095A (en) Salts of omega-3-polyunsaturated fatty acids and pharmaceutical formulations containing them
HUP9800120A3 (en) Pharmaceutical compositions of neutral taste containing quinolon derivatives as active components and process for producing them
HUT45537A (en) Process for producing delta-22 derivatives of ll-f 28249 compounds and pharmaceutical compositions containing them as active components, and insecticide compositions
HUT52388A (en) Process for producing pharmaceutical compositions comprising unsaturated fatty acids and selenium as active ingredient
EP0652755A1 (en) THERAPEUTIC USE OF PHOSPHORYL-L-SERINE-N-ACYL-SPHINGOSINE.
HUT50762A (en) Process for production of medical compositions containing as active substance derivatives of pirrol and process for production of the active substance
GB2204793A (en) Hair restorer formulation
JPH0645530B2 (ja) 皮膚外用剤
HU904062D0 (en) Process for producing substituted 3-amino-sydnonimines and pharmaceutical preparations containing these compounds as active substance
HUT55957A (en) Herbicide compositions containing amides of pyrazolo-3-carboxylic acid as active component and process for producing the active components
HUT44005A (en) Insecticide and acaricide compositions containing esters of carbamic acids as active components and process for producing the active components
JPH0632710A (ja) 皮膚外用剤
HUT41598A (en) Insecticide and acaricide compositions containing omega-naphthoxy-alkene- /or-alkadiene-/ -carboxylic acid amide derivatives as active ingredients and process for preparing the active ingredients